2-chloro-n(6)cyclopentyladenosine has been researched along with n(6)-cyclopentyladenosine in 24 studies
Studies (2-chloro-n(6)cyclopentyladenosine) | Trials (2-chloro-n(6)cyclopentyladenosine) | Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine) | Studies (n(6)-cyclopentyladenosine) | Trials (n(6)-cyclopentyladenosine) | Recent Studies (post-2010) (n(6)-cyclopentyladenosine) |
---|---|---|---|---|---|
252 | 0 | 43 | 605 | 0 | 62 |
Protein | Taxonomy | 2-chloro-n(6)cyclopentyladenosine (IC50) | n(6)-cyclopentyladenosine (IC50) |
---|---|---|---|
Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.2256 | |
Adenosine receptor A2b | Rattus norvegicus (Norway rat) | 1.16 | |
Adenosine receptor A1 | Homo sapiens (human) | 0.0027 | |
Adenosine receptor A2a | Rattus norvegicus (Norway rat) | 1.16 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (33.33) | 18.2507 |
2000's | 11 (45.83) | 29.6817 |
2010's | 4 (16.67) | 24.3611 |
2020's | 1 (4.17) | 2.80 |
Authors | Studies |
---|---|
Jacobson, KA; van Galen, PJ; Williams, M | 1 |
Daly, JW; Olsson, RA; Secunda, S; Thompson, RD | 1 |
Jacobson, KA; Ji, XD; Kim, HO; Olah, ME; Siddiqi, SM; Stiles, GL | 1 |
Fredholm, BB; Hegler, J; Hessling, J; Klotz, KN; Kull, B; Lohse, MJ; Owman, C | 1 |
Cappellacci, L; Franchetti, P; Grifantini, M; Lucacchini, A; Marchetti, S; Martini, C; Mazzoni, MR; Trincavelli, L | 1 |
Barbhaiya, H; IJzerman, AP; Rivkees, SA | 1 |
Figler, H; Jin, X; Linden, J; Robeva, AS; Thai, T | 1 |
Costanzi, S; Cristalli, G; IJzerman, AP; Kunzel, JK; Lorenzen, A; Stannek, C; Vittori, S; Volpini, R | 1 |
Jacobson, KA; Ji, X; Li, AH; Marquez, VE; Melman, N; Ravi, RG; Shin, KJ; Siddiqui, MA | 1 |
de Groote, M; IJzerman, AP; Lorenzen, A; Stannek, C; van der Klein, PA; van Tilburg, EW; von Frijtag Drabbe Künzel, J | 1 |
Barak, D; Biadatti, T; Chen, W; Gao, ZG; Jacobson, KA; Johnson, CR; Kim, SG; Kim, SK; Lee, K | 1 |
Duong, HT; Gao, ZG; Jacobson, KA; Joshi, BV; Liang, BT; Sonin, D; Tchilibon, S | 1 |
Gao, ZG; Jacobson, KA | 1 |
Cappellacci, L; Costa, B; Franchetti, P; Grifantini, M; Klotz, KN; Lavecchia, A; Martini, C; Petrelli, R; Spinetti, F; Vita, P | 1 |
Cappellacci, L; Franchetti, P; Graser, G; Grifantini, M; Jayaram, HN; Lavecchia, A; Petrelli, R; Saiko, P; Szekeres, T; Vita, P | 1 |
Coleman, J; Fitzpatrick, BJ; Frye, SV; Hull-Ryde, EA; Janzen, WP; Jin, J; Korboukh, I; Randhawa, AS; Rittiner, JE; Setola, V; Zylka, MJ | 1 |
Deflorian, F; Gao, ZG; Jacobson, KA; Jiang, X; Moss, SM; Paoletta, S; Phan, K; Tosh, DK | 1 |
Amin, EA; Dosa, PI | 1 |
Auchampach, JA; Bitant, A; Ciancetta, A; Cui, Z; Gao, ZG; Gavrilova, O; Jacobson, KA; Lieberman, DI; Liu, N; Mannes, P; Mattison, JA; Rao, H; Reitman, ML; Rothwell, AC; Salmaso, V; Tosh, DK; Vaughan, KL | 1 |
Antonelli, MC; Giraldez, L; Girardi, E; Rodríguez de Lores Arnaiz, G; Zanetti, F | 1 |
Hashimoto, K; Iyo, M; Komatsu, N; Kumakiri, C; Okamura, N; Shimizu, E | 1 |
Aqvist, J; Centeno, NB; Gutiérrez-de-Terán, H; Pastor, M; Sanz, F | 1 |
Cao, Y; Jin, L; Meng, F; Sun, WC; Wang, LZ; Zhu, XZ | 1 |
Langston, JL; Meads, KL; Myers, TM; Shih, TM; Thomas, TP | 1 |
3 review(s) available for 2-chloro-n(6)cyclopentyladenosine and n(6)-cyclopentyladenosine
Article | Year |
---|---|
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.
Topics: Adenosine; Animals; Humans; Models, Chemical; Receptors, Purinergic; Second Messenger Systems; Structure-Activity Relationship | 1992 |
Adenosine receptors as therapeutic targets.
Topics: Animals; Disease; Drug Therapy; Humans; Ligands; Molecular Structure; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Signal Transduction; Structure-Activity Relationship | 2006 |
Tactical Approaches to Interconverting GPCR Agonists and Antagonists.
Topics: Animals; Humans; Ligands; Models, Molecular; Molecular Structure; Receptors, G-Protein-Coupled; Structure-Activity Relationship | 2016 |
21 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and n(6)-cyclopentyladenosine
Article | Year |
---|---|
Activity of N6-substituted 2-chloroadenosines at A1 and A2 adenosine receptors.
Topics: 2-Chloroadenosine; Animals; Brain; In Vitro Techniques; Rats; Receptors, Purinergic; Structure-Activity Relationship | 1991 |
2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors.
Topics: Adenosine; Adenylyl Cyclase Inhibitors; Animals; Brain; Cell Membrane; CHO Cells; Cricetinae; Molecular Structure; Rats; Receptors, Purinergic P1; Recombinant Proteins; Structure-Activity Relationship | 1994 |
Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Base Composition; Binding, Competitive; CHO Cells; Cricetinae; Guanylate Cyclase; Humans; Phenethylamines; Phenylisopropyladenosine; Receptors, Purinergic P1; Stereoisomerism; Structure-Activity Relationship; Transfection; Xanthines | 1998 |
2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adenylyl Cyclase Inhibitors; Animals; Brain; Cattle; Enzyme Inhibitors; In Vitro Techniques; Male; Membranes; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Testis | 1998 |
Identification of the adenine binding site of the human A1 adenosine receptor.
Topics: Adenine; Amides; Amino Acid Sequence; Amino Acids; Binding Sites; DNA, Complementary; Humans; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Receptors, Purinergic P1 | 1999 |
Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells.
Topics: Animals; Anti-Asthmatic Agents; Blotting, Western; Calcium; Cell Degranulation; Cells, Cultured; CHO Cells; Cricetinae; Cyclic AMP; GTP-Binding Proteins; Humans; Kidney; Mast Cells; Purinergic P1 Receptor Agonists; Radioligand Assay; Receptor, Adenosine A2B; Receptors, Purinergic P1; Theophylline; Type C Phospholipases; Xanthines | 1999 |
N-cycloalkyl derivatives of adenosine and 1-deazaadenosine as agonists and partial agonists of the A(1) adenosine receptor.
Topics: Adenosine; Animals; Brain; Guanosine 5'-O-(3-Thiotriphosphate); Magnetic Resonance Spectroscopy; Phenethylamines; Purinergic P1 Receptor Agonists; Radioligand Assay; Rats; Tubercidin; Xanthines | 2000 |
Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists.
Topics: Animals; Cell Membrane; CHO Cells; Cricetinae; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Purine Nucleosides; Purinergic P1 Receptor Agonists; Radioligand Assay; Rats; Sulfur Radioisotopes | 2000 |
5'-O-alkyl ethers of N,2-substituted adenosine derivatives: partial agonists for the adenosine A1 and A3 receptors.
Topics: Adenosine; Animals; Binding, Competitive; Cell Line; Cerebral Cortex; Cricetinae; Cyclic AMP; Humans; In Vitro Techniques; Purinergic P1 Receptor Agonists; Radioligand Assay; Rats; Receptor, Adenosine A3; Receptors, Purinergic P1; Structure-Activity Relationship | 2001 |
Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary.
Topics: Adenosine; Animals; Binding, Competitive; CHO Cells; Cricetinae; Epoxy Compounds; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ligands; Models, Molecular; Mutation; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Receptor, Adenosine A3; Receptors, Purinergic P1; Ribose; Spiro Compounds; Stereoisomerism; Structure-Activity Relationship | 2002 |
Semi-rational design of (north)-methanocarba nucleosides as dual acting A(1) and A(3) adenosine receptor agonists: novel prototypes for cardioprotection.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Agonists; Adenosine A3 Receptor Agonists; Animals; Cardiotonic Agents; CHO Cells; Cricetinae; Drug Design; Humans; Mice; Myocardial Infarction; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptor, Adenosine A3; Reperfusion Injury; Ventricular Function, Left | 2005 |
5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species.
Topics: Adenosine A1 Receptor Agonists; Animals; Carbamates; Cattle; Computer Simulation; Humans; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Protein Binding; Purine Nucleosides; Static Electricity; Structure-Activity Relationship; Swine | 2008 |
Ribose-modified purine nucleosides as ribonucleotide reductase inhibitors. Synthesis, antitumor activity, and molecular modeling of N6-substituted 3'-C-methyladenosine derivatives.
Topics: Adenosine; Antineoplastic Agents; Cell Line, Tumor; Enzyme Inhibitors; Humans; Ribonucleotide Reductases; Ribose; Structure-Activity Relationship | 2008 |
Orally active adenosine A(1) receptor agonists with antinociceptive effects in mice.
Topics: Adenosine A1 Receptor Agonists; Adenosine Monophosphate; Administration, Oral; Analgesics; Animals; Behavior, Animal; HEK293 Cells; Humans; Male; Mice; Nociception; Receptor, Adenosine A1; Substrate Specificity; Temperature | 2012 |
Structural sweet spot for A1 adenosine receptor activation by truncated (N)-methanocarba nucleosides: receptor docking and potent anticonvulsant activity.
Topics: Animals; Anticonvulsants; CHO Cells; Cricetinae; Cricetulus; Humans; Male; Mice; Molecular Docking Simulation; Nucleosides; Protein Conformation; Receptor, Adenosine A1; Structure-Activity Relationship | 2012 |
Design and in Vivo Characterization of A
Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Bridged Bicyclo Compounds; CHO Cells; Cricetulus; Drug Design; HEK293 Cells; Humans; Macaca fascicularis; Male; Mice, Inbred C57BL; Molecular Docking Simulation; Molecular Structure; Receptor, Adenosine A1; Structure-Activity Relationship | 2019 |
CNS adenosine A1 receptors are altered after the administration of convulsant 3-mercaptopropionic acid and cyclopentyladenosine: an autoradiographic study.
Topics: 3-Mercaptopropionic Acid; Adenosine; Animals; Anticonvulsants; Autoradiography; Brain; Convulsants; Injections, Intraperitoneal; Male; Rats; Rats, Wistar; Receptors, Purinergic P1 | 1998 |
Adenosine A1 receptor agonists block the neuropathological changes in rat retrosplenial cortex after administration of the NMDA receptor antagonist dizocilpine.
Topics: Acetylcholine; Adenosine; Adenosine A1 Receptor Agonists; Animals; Cerebral Cortex; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Female; HSP70 Heat-Shock Proteins; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptors, N-Methyl-D-Aspartate | 2004 |
Comparative analysis of putative agonist-binding modes in the human A1 adenosine receptor.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine-5'-(N-ethylcarboxamide); Binding Sites; Humans; Mathematics; Models, Molecular; Receptor, Adenosine A1; Thermodynamics | 2004 |
Modulating effect of adenosine deaminase on function of adenosine A1 receptors.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine Deaminase; Calcium; Cell Line; Cell Membrane; Embryo, Mammalian; Humans; Kidney; Radioligand Assay; Receptor, Adenosine A1; Signal Transduction; Xanthines | 2005 |
Evaluation of adenosine A1 receptor agonists as neuroprotective countermeasures against Soman intoxication in rats.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Anticonvulsants; Behavior, Animal; Brain; Deoxyadenosines; Disease Models, Animal; Male; Neuroprotective Agents; Organophosphate Poisoning; Rats, Sprague-Dawley; Receptor, Adenosine A1; Seizures; Soman | 2021 |